Targeted cancer therapy is still a major challenge.Current chemothera-poetic drugs lack selectivity and are associated with major side-effects and lack of efficacy in many patients.Targeted drug delivery is important in cancer therapy to decrease the systemic toxicity resulting from nonspecific drug distribution and to enhance drug delivery efficiency.Recently our group have developed a nucleic acid aptamer for therapeutic targeted-delivery applications.